Cargando…

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose

PURPOSE: This study aimed to compare the adverse reactions of conventional-dose and hypofractionated dose of proton therapy for breast cancer. MATERIALS AND METHODS: Breast cancer patients treated with proton radiotherapy in conventional-dose or hypofractionated dose were studied retrospectively. RE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, ZhengShan, Yang, ZhaoZhi, Mei, Xin, Li, Ping, Bao, Cihang, Wang, Zheng, Cai, Xin, Ming, Xue, Wang, WeiWei, Guo, XiaoMao, Yu, XiaoLi, Zhang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035215/ https://www.ncbi.nlm.nih.gov/pubmed/36959653 http://dx.doi.org/10.1186/s13014-023-02213-8

Ejemplares similares

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
por: Vaidya, Jayant S., et al.
Publicado: (2021)

Lumpectomy Combined with Adjuvant Radiotherapy Could Be a Treatment Option for Primary Squamous Cell Carcinoma of the Breast
por: Qi, Wei Xiang, et al.
Publicado: (2021)

Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer
por: Hu, Wei, et al.
Publicado: (2022)

Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
por: Guo, Wei, et al.
Publicado: (2019)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification
por: Wei, Shouyi, et al.
Publicado: (2022)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
por: Li, Dongqing, et al.
Publicado: (2021)

Lung dose analysis in loco-regional hypofractionated radiotherapy of breast cancer
por: Attar, Mohammad A., et al.
Publicado: (2016)

Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer
por: Zhao, Xianlan, et al.
Publicado: (2022)

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
por: HUANG, BING-SHEN, et al.
Publicado: (2013)

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens
por: Sudahar, H., et al.
Publicado: (2012)

Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
por: Wang, Xiaofang, et al.
Publicado: (2021)

Correlation between Biological Effective Dose and Radiation-induced Liver Disease from Hypofractionated Radiotherapy
por: Bergamo, Angelo M., et al.
Publicado: (2019)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model
por: Wang, Weiwei, et al.
Publicado: (2021)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Comparison  of  efficacy, safety, and costs between neoadjuvant hypofractionated radiotherapy and conventionally fractionated radiotherapy for esophageal carcinoma
por: Lyu, Jiahua, et al.
Publicado: (2019)

Intraoperative Radiotherapy Versus Whole-Breast External Beam Radiotherapy in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2015)

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
por: Murray, Julia, et al.
Publicado: (2020)

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
por: Borm, Kai J., et al.
Publicado: (2020)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Multibeam inverse intensity-modulated radiotherapy (IMRT) for whole breast irradiation: a single center experience in China
por: Yang, Zhaozhi, et al.
Publicado: (2015)

Hypofractionated stereotactic radiotherapy for large arteriovenous malformations
por: Wang, Huan-Chih, et al.
Publicado: (2012)

Comparison of Treatment Outcome between Hypofractionated Radiotherapy and Conventional Radiotherapy in Postmastectomy Breast Cancer
por: Tovanabutra, Chokaew, et al.
Publicado: (2020)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
por: Sanguineti, Giuseppe, et al.
Publicado: (2019)

Intensity modulated radiotherapy with fixed collimator jaws for locoregional left-sided breast cancer irradiation
por: Wang, Juanqi, et al.
Publicado: (2017)

Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy: Results of a single, institutional, retrospective study
por: Rudat, Volker, et al.
Publicado: (2017)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Visualization of the tumor cavity after lumpectomy of breast cancer for postoperative radiotherapy
por: Ciernik, Ilja F., et al.
Publicado: (2018)

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
por: Bertholet, Jenny, et al.
Publicado: (2019)

Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study
por: de la Pinta, Carolina, et al.
Publicado: (2020)

Isolated locoregional recurrence patterns of breast cancer after mastectomy and adjuvant systemic therapies in the contemporary era
por: Ma, Jinli, et al.
Publicado: (2015)

Intraoperative ultrasound-guided lumpectomy versus wire-guided excision for nonpalpable breast cancer
por: Hu, Xin, et al.
Publicado: (2020)

Quantitative Assessment of 3D Dose Rate for Proton Pencil Beam Scanning FLASH Radiotherapy and Its Application for Lung Hypofractionation Treatment Planning
por: Kang, Minglei, et al.
Publicado: (2021)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

A Comparative Study of Hypofractionated and Conventional Radiotherapy in Postmastectomy Breast Cancer Patients
por: Rastogi, Kartick, et al.
Publicado: (2018)

Are we ready to use hypofractionated instead of conventional radiotherapy for prostate cancer? Not yet
Publicado: (2019)

Treatment completion rates and toxicity of 5 fractions of adjuvant radiotherapy over one week in elderly breast cancer patients treated with lumpectomy
por: Flores Sánchez, Álvaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mdsit132njtfi7csej2cdlv6s1